Jincheng Wang

Title: Jincheng Wang: Innovator in Serotonin Modulation

Introduction

Jincheng Wang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate serotonin receptors. His work is essential for advancing treatments for various conditions related to serotonin dysregulation.

Latest Patents

Wang holds a patent for "Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators." This invention relates to a compound of formula (I), which consists of tricyclic hexahydrodiazepinoquinolines carrying a cyclic substituent. These compounds are useful for modulating the 5-HT receptor and can help prevent and treat conditions that respond to this modulation. The patent also covers methods for producing these compounds and pharmaceutical compositions containing them.

Career Highlights

Throughout his career, Jincheng Wang has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH and Co. KG. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Wang has collaborated with several professionals in his field, including Gisela Backfisch and Margaretha Henrica Maria Bakker. These collaborations have enriched his research and development efforts, leading to innovative solutions in pharmacology.

Conclusion

Jincheng Wang's contributions to the field of serotonin modulation through his patented inventions highlight his role as an influential inventor. His work continues to pave the way for advancements in treating conditions related to serotonin receptors.